CD274 and Merkel cell skin cancer: demonstrated that both virus-positive and virus-negative MCC tumors exhibit upregulation of the PD-1/PD-L1 axis, potentially explaining the broad efficacy of checkpoint inhibitors across MCC subtypes (45).